Lv4
550 积分 2023-04-25 加入
Standardized antibody purification process development workflow using a novel gravity column-based high throughput method
2个月前
已完结
Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4– and PD-1–targeted immunotherapy
3个月前
已完结
De novo design of potent and selective mimics of IL-2 and IL-15
5个月前
已完结
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
6个月前
已完结
Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC
7个月前
已完结
Rekindling cancer vaccines
7个月前
已完结
Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
7个月前
已完结
Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti–PD-1 Immunotherapy
7个月前
已完结
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus
8个月前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
8个月前
已完结
皖公网安备34019202002308
